Dry January isn't new, but it's evolving. Even people who wrote off Dry January in years past are taking this month as an opportunity to consider their alcohol consumption. For most of us, with months of lockdowns and stress these past couple of years, a little less at-home drinking won't hurt.
So what do we drink instead?
THE TREND: CBD Beverages. But what is CBD and how do we use it effectively? This email is longer than we typically send, but we know that people nationwide are sober-curious and excited about CBD and this trend requires some education to fully understand.
What is CBD? CBD is one of the most common, natural compounds (“cannabinoids”) found in the Cannabis sativa plant. Unlike the other most common cannabinoid, THC, CBD has no psychoactive characteristics. Translation: CBD is 100% natural, safe, and will not get you high.
WHY IS CBD SO POPULAR? By 2023, the market is expected to be valued at $1.4 billion, more than 16 times its 2018 size. As global research and surveys increasingly report, CBD has shown vast therapeutic and health benefits. Among the most commonly cited: reduced anxiety, reduced inflammation and chronic pain, improved sleep, and eased depressive symptoms. All this from a plant grown on the land, not a pill made in a lab.
HOW DO WE KNOW? A new clinical trial conducted by CBD bioscience company CFH finds that a twice daily regime of 25 mg CBD and terpene soft gels significantly reduces inflammatory marker scores by 29.4 percent. ** FULL PRESS RELEASE BELOW.
WHY CBD BEVERAGES? Beverages have a quicker onset time and more efficient use of CBD than oil tinctures and traditional edibles because they use water-soluble CBD. This characteristic allows your body to absorb more of the CBD and quicker - delivering greater benefits and a stronger correlation and confidence with the effectiveness of the product. Consumers are increasingly following reduced-drinking and sober-period trends. Lack of appealing alternatives, and social pressure and comfort are documented as common obstacles for these ‘sober-curious’ groups. CBD seltzers not only taste delicious and feature an ingredient that eases social anxiety, but in a glass they look like a cocktail, and can also be used as ingredients to make delicious non-alcoholic mocktails.
TRY IT (SAMPLES): Try two different brands of CBD Seltzers for yourself - James & James and Oh Hi CBD Seltzers. Both brands are available online and ship nationwide.
Oh Hi's lineup of flavor-forward sparking CBD seltzers contain 20mg of CBD and stand out in a sea of bland seltzer options with 5g of pure cane sugar in every can for maximum flavor. Four flavors, Pomegranate, Lemon Lime, Ginger Basil Limeade and Grapefruit, are now available to ship nationwide.
James & James is the first craft sparkling beverage made with full spectrum, hemp flower-derived CBD extract sourced from in-house hemp. Each 12 oz glass bottle of James & James features 25mg of CBD sourced from its parent company CFH Ltd.’s Colorado farm. James & James' two flavors, Cucumber Mint and Cherry Vanilla, are carbonated, light and refreshing with the subtle touch of earthy hemp and are naturally alcohol-free, caffeine-free, gluten-free and contain zero calories, sugars/or carbs.
# # #
FOR IMMEDIATE RELEASE Clinical Trial Finds Inflammatory Marker Scores Significantly Improve With Use of CFH, Ltd.’s Full-spectrum Hemp Flower-Derived CBD
The new study shows CBD significantly reduces inflammatory marker scores by nearly 30 percent
Longmont, Colo., December 2021 -- A new clinical trial conducted by CBD bioscience company CFH, Ltd., in collaboration with Inflammatory Markers Laboratory, finds that a twice daily regime of 25 mg full spectrum hemp flower-derived CBD and terpene soft gels significantly reduces inflammatory marker scores by 29.4 percent. Check out the clinical trial results here at CFH.Ltd.
This double-blind, placebo-controlled study measured the effect of CFH’s full-spectrum hemp flower-derived CBD and terpene preparation on chronic inflammation over the course of 6 weeks.
“Ongoing inflammation is a major cause of chronic disease and pain. Having tools like CBD that have been shown to help control the runaway inflammatory process is very important to managing the symptoms of inflammatory diseases,” says CFH’s Clinical Science Director Dr. Karen Hufnagl, DC, MS.
Participants in the CFH study were evaluated for levels of 11-Dehydro Thromboxane B2 via urine specimens by blinded scientists at the Inflammatory Markers Laboratory. The 11-Dehydro Thromboxane B2 compound increases with inflammation and inflammatory diseases such as heart disease, peripheral artery disease, stroke, diabetes, cancer, Alzheimer’s disease, obesity, and hypertension.
The group who received the full spectrum hemp flower-derived CBD and terpene soft gels showed a significant reduction of 29.4 percent in their inflammatory marker scores, while the group receiving the placebo saw no significant change in their inflammatory marker scores.
This clinical trial adds to the body of evidence showing the ability of CBD to support a normal inflammatory response, and in particular, documents the improvement of chronic inflammatory marker scores with the use of CFH’s full-spectrum hemp flower-derived CBD product, which also contains a robust and extensive profile of naturally occurring cannabinoids and terpenes.
“It’s pretty profound that as a daily regime, CBD is able to change the course of chronic inflammation and can positively impact the many illnesses related to inflammation,” says Dr. Hufnagl. “We are excited to continue contributing to the growing body of data that shows that CBD is safe and effective.”
Dr. Hufnagl is also the founder of In Avanti Health, a Functional Medicine Practice based in Colorado. With more than 20 years of experience, Dr. Hufnagl has one foot in everyday clinical practice and the other in product development and research. She specializes in thyroid and hormone imbalances and is also dedicated to helping athletes reduce pain and inflammation, maximize their recovery and performance, and reach new heights in their athletic pursuits.
About CFH, Ltd. Founded in 2014, CFH, Ltd. is Colorado-based, vertically integrated CBD bioscience company and a leading supplier of CBD nationwide. CFH is committed to producing the highest quality full spectrum CBD and proprietary hemp strains that maintain the natural balance and proportion of the cannabinoids and terpenes present in hemp plants to provide optimal health benefits and efficacy. In addition to CBD as a major component, CFH's full spectrum hemp flower derived products contain an extensive profile of cannabinoids, terpenes and flavonoids. For more information on CFH, visit CFH.Ltd.